This inventor holds 1 USPTO granted patent. Top assignee: Rijksuniversiteit Groningen. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Alexander Dömling: Innovator in Arginase Inhibitors
Introduction
Alexander Dömling is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that target arginase activity. His work is crucial for addressing various health conditions.
Latest Patents
Dömling holds a patent for arginase inhibitors, which are described in his invention as novel compounds useful in treating diseases associated with arginase activity. These include asthma, allergic rhinitis, and chronic obstructive pulmonary disease (COPD). His patent represents a significant advancement in therapeutic options for these conditions.
Career Highlights
Dömling is affiliated with Rijksuniversiteit Groningen, where he engages in research and development of innovative solutions in the pharmaceutical field. His academic background and research focus have positioned him as a key figure in the study of arginase inhibitors.
Collaborations
One of his notable collaborators is Santosh Kurhade, with whom he has worked on various projects related to his research interests. Their partnership exemplifies the collaborative nature of scientific research, leading to advancements in their field.
Conclusion
Alexander Dömling's work on arginase inhibitors highlights his commitment to improving health outcomes through innovative research. His contributions are paving the way for new treatments for diseases linked to arginase activity.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile